Maduck Sean: insider trades.
Maduck Sean reported 20 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 11 sales ($11.8M), across 1 company.
- Transactions
- 20
- Purchases (P)
- 0
- Sales (S)
- 11
- Companies
- 1
- Name as filed
- Maduck Sean
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Corcept Therapeutics Inc (CORT) | Officer · See Remarks | 20 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Corcept Therapeutics Inc | F | 117 | $113.38 | 9,938 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | S | 11,730 | $113.94 | 23,025 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | A | 150 | $113.38 | 9,905 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | S | 2,281 | $115.61 | 9,755 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | S | 10,989 | $114.71 | 12,036 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | M | 25,000 | $8.27 | 34,755 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | A | 150 | $0 | 10,055 | Form 4 |
| 2026-08-25 | Corcept Therapeutics Inc | S | 5,870 | $126.06 | 9,755 | Form 4 |
| 2026-08-25 | Corcept Therapeutics Inc | M | 30,955 | $11.35 | 40,710 | Form 4 |
| 2026-08-25 | Corcept Therapeutics Inc | S | 25,085 | $125.47 | 15,625 | Form 4 |
| 2026-08-14 | Corcept Therapeutics Inc | M | 3,664 | $8.27 | 13,419 | Form 4 |
| 2026-08-14 | Corcept Therapeutics Inc | S | 3,664 | $114.49 | 9,755 | Form 4 |
| 2026-08-10 | Corcept Therapeutics Inc | M | 1,031 | $8.27 | 10,786 | Form 4 |
| 2026-08-10 | Corcept Therapeutics Inc | S | 1,031 | $114.52 | 9,755 | Form 4 |
| 2026-08-03 | Corcept Therapeutics Inc | M | 20,305 | $8.27 | 30,060 | Form 4 |
| 2026-08-03 | Corcept Therapeutics Inc | S | 20,305 | $114.7 | 9,755 | Form 4 |
| 2026-07-01 | Corcept Therapeutics Inc | S | 11,024 | $87.33 | 23,731 | Form 4 |
| 2026-07-01 | Corcept Therapeutics Inc | S | 2,801 | $88.51 | 20,930 | Form 4 |
| 2026-07-01 | Corcept Therapeutics Inc | M | 25,000 | $8.27 | 34,755 | Form 4 |
| 2026-07-01 | Corcept Therapeutics Inc | S | 11,175 | $89.31 | 9,755 | Form 4 |
Questions
What stock did Maduck Sean buy or sell?
Maduck Sean reported 20 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 11 sales ($11.8M), across 1 company.
Is Maduck Sean the same person as other filers with this name?
This page covers SEC CIK 1698310 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/maduck-sean-1698310.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.